While promising in research for fat metabolism and potentially cartilage repair, large trials showed good efficacy with AOD9604 for obesity, but it remains a research tool for studying fat burning and metabolic pathways, often used off-label in wellness settings alongside diet and exercise with promising affects for cartilage repair
Within hours of treatment, research models begin showing increased NAD+ levels and reduced 1-MNA production, but the full spectrum of metabolic changes develops over days to weeks as downstream signaling cascades adjust to the new metabolic environment
Reducing the risk of metabolic diseases: Inhibiting NNMT may counteract the adverse metabolic changes associated with obesity, such as fatty liver disease
Originally developed by Metabolic Pharmaceuticals Ltd
For researchers seeking alternatives to GLP-1 agonists or stimulants, 5-amino-1mq offers an interesting option
1 week (4 vials 2.0 mL = 8 mL) 1 10 mL bottle 2 weeks (7 vials 2.0 mL = 14 mL) 2 10 mL bottles 4 weeks (14 vials 2.0 mL = 28 mL) 3 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each administration